Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Magdalena Magnowska"'
Autor:
Emilia Gąsiorowska, Magdalena Magnowska, Ewa Nowak-Markwitz, Natalia Iżycka, Wojciech Warchoł
Publikováno v:
Polish Gynaecology. 87:260-264
Objectives: The incidence of endometrial cancer is constantly growing. More aggressive types of endometrial cancer as well as the incidence in younger women is being observed. More than 80% of cases is diagnosed in early stages due to early symptoms
Autor:
Marek Spaczyński, Anna Romała, Magdalena Magnowska, Ewa Nowak-Markwitz, Natalia Iżycka, Joanna Kapoła-Czyż, Jakub Lorek
Publikováno v:
Ginekologia polska. 89(4)
Objectives: Chemotherapy-induced peripheral neuropathy (CIPN) is a common chemotherapy side effect, but its prevention and treatment remains a challenge. Neurotoxicity may lead to dose limitation or even treatment discontinuation, and therefore poten
Autor:
Andrzej Frankowski, Magdalena Magnowska, Agnieszka Lemańska, Marek Spaczyński, Ewa Nowak-Markwitz, Paulina Banach
Publikováno v:
Archives of Medical Science. 1:240-252
Vulvar melanoma is an aggressive neoplasm with a poor prognosis. Approximately 25% to 50% of patients survive 5 years [1]. This malignancy is prone to late metastasis, so 5-year survival does not equal cure. The management of recurrent disease contin
Autor:
Wojciech Rzeszutko, Marek Spaczyński, Andrzej Frankowski, Magdalena Magnowska, Ewa Nowak-Markwitz
Publikováno v:
Archives of Medical Science. 1:237-239
The incidence of endometrial cancer (EC) in the population of young women has been increasing. Total hysterectomy with bilateral salpingo-oophorectomy remains the standard therapy for early endometrial cancer [1]. However, doctor and patient attitude
Autor:
Emilia, Gąsiorowska, Magdalena, Magnowska, Natalia, Iżycka, Wojciech, Warchoł, Ewa, Nowak-Markwitz
Publikováno v:
Ginekologia polska. 87(4)
The incidence of endometrial cancer is constantly growing. More aggressive types of endometrial cancer as well as the incidence in younger women is being observed. More than 80% of cases is diagnosed in early stages due to early symptoms like abnorma
Autor:
Ewa Nowak-Markwitz, Andrzej Wróbel, Aleksandra Filipczak, Tomasz Rechberger, Magdalena Magnowska, Ewa Rechberger, Paulina Banach, Marek Spaczyński
Publikováno v:
Ginekologia polska. 86(11)
Introduction Malignant tumours are rarely diagnosed during pregnancy, and their prevalence range from 2.4% to5.7%. Ovarian cancer is ranked fifth of all types of cancer and second of all genital cancers diagnosed during pregnancy. In most cases, the
Autor:
Maciej Zabel, Magdalena Magnowska, Mikołaj Zaborowski, Ewa Nowak-Markwitz, Marek Spaczyński, Pawel Surowiak
Publikováno v:
Ginekologia polska. 85(5)
Objective: Numerous studies suggest that cyclooxygenase-2 (COX-2) is overexpressed in cancer. Our objective was to investigate the relationship between COX-2 expression in ovarian carcinoma and clinicopathological factors. An emphasis was put on the
Autor:
Agnieszka, Lemańska, Paulina, Banach, Magdalena, Magnowska, Andrzej, Frankowski, Ewa, Nowak-Markwitz, Marek, Spaczyński
Publikováno v:
Archives of Medical Science : AMS
Autor:
Magdalena, Magnowska, Paweł, Surowiak, Ewa, Nowak-Markwitz, Marcin, Michalak, Piotr, Magnowski, Wojciech, Rokita, Helena, Kedzia, Maciej, Zabel, Marek, Spaczyński
Publikováno v:
Ginekologia polska. 79(12)
Loss of DNA mismatch repair may result in resistance to platinum- based anticancer drugs. The hMLH1 and hMSH2 proteins play a critical role in the maintenance of genome integrity and are involved in resistance to platinum-based therapy in colorectal
Autor:
Piotr, Magnowski, Krzysztof, Medrek, Magdalena, Magnowska, Małgorzata, Stawicka, Helena, Kedzia, Bohdan, Górski, Jan, Lubiński, Marek, Spaczyński
Publikováno v:
Ginekologia polska. 79(8)
There is an increasing evidence that genetic factors play a role in the etiology of malignant tumors. Mutations of BRCA1 and BRCA2 genes are responsible for an increased risk of ovarian cancer. The role of mutations in NOD2 gene in this type of neopl